GW Pharmaceuticals PLC (NASDAQ:GWPH)

88.32
BATS BZX Real-Time Price
As of 1:58pm ET
 +2.51 / +2.93%
Today’s Change
67.98
Today|||52-Week Range
196.00
-15.53%
Year-to-Date
Is This the Most Undervalued Cannabis Stock?
Mar 18 / MotleyFool.com - Paid Partner Content
Will COVID-19 Derail New Drugs?
Mar 18 / MotleyFool.com - Paid Partner Content
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
Mar 18 / MotleyFool.com - Paid Partner Content
Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today
Mar 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close85.81
Today’s open86.84
Day’s range86.66 - 89.63
Volume5,518
Average volume (3 months)657,402
Market cap$2.7B
Data as of 1:54pm ET, 03/30/2020

Growth & Valuation

Earnings growth (last year)+96.96%
Earnings growth (this year)-466.47%
Earnings growth (next 5 years)+42.59%
Revenue growth (last year)+1,918.66%
P/E ratioNM
Price/Sales--
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+1.91+4.75%
MYOKMyoKardia Inc-2.07-3.87%
RAREUltragenyx Pharmaceu...+1.07+2.52%
----
Data as of 1:59pm ET, 03/30/2020

Financials

Next reporting dateMay 11, 2020
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$312.6M
Annual profit (last year)-$9.1M
Net profit margin-2.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts